AVLSA
Atlas Venture Life Science Advisors Portfolio holdings
AUM
$753M
1-Year Est. Return
26.6%
1 Year Est. Return
+26.6%
AUM
$753M
AUM Growth
+$90.3M
(+14%)
Holding
11
Top Buys
No buys this quarter
Top Sells
| 1 | +$56.5M | |
| 2 | +$46.4M | |
| 3 | +$16M | |
| 4 |
SION
Sionna Therapeutics
SION
|
+$2.31M |
| 5 |
IMA
ImageneBio Inc
IMA
|
+$329K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Kymera Therapeutics
KYMR
$4.81B
| $277M | 36.82% |
4,896,462
|
|
||
2
Disc Medicine
IRON
$3.46B
| $142M | 18.81% |
2,142,617
-241,839
|
|
||
3
Dyne Therapeutics
DYN
$2.94B
| $116M | 15.35% |
9,130,465
|
|
||
|
SION
4
Sionna Therapeutics
SION
$1.74B
| $106M | 14.13% |
3,615,527
-78,493
|
|
||
5
Korro Bio
KRRO
$50.7M
| $54.5M | 7.24% |
1,137,149
|
|
||
6
Day One Biopharmaceuticals
DAWN
$901M
| $45.3M | 6.02% |
6,430,257
|
|
||
7
Generation Bio
GBIO
$34M
| $5.07M | 0.67% |
827,946
-2
|
|
||
8
Q32 Bio
QTTB
$47M
| $4.14M | 0.55% |
2,092,106
|
|
||
|
IMA
9
ImageneBio Inc
IMA
$74.9M
| $3.08M | 0.41% |
377,814
-40,368
|
|
||
|
THRD
10
DELISTED
Third Harmonic Bio
THRD
| – | – |
-10,402,286
|
|
||
|
VIGL
11
DELISTED
Vigil Neuroscience
VIGL
| – | – |
-5,836,874
|
|